Relationship of dose schedules to the effectiveness of adjuvant chemotherapy.
D000230:Adenocarcinoma / Q000188:drug therapy; D000671:Amputation, Surgical; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004195:Disease Models, Animal; D005260:Female; D005910:Glioma / Q000188:drug therapy; D006614:Hindlimb / Q000601:surgery; D006824:Hybridization, Genetic; D006940:Hyperemia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009364:Neoplasm Recurrence, Local; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000139:chemically induced; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010689:Phlebitis / Q000139:chemically induced; D011878:Radiotherapy / Q000009:adverse effects
D000970:Antineoplastic Agents; D003520:Cyclophosphamide